DMN:FRA
Diamyd Medical AB
0,063 €
0,00%
(0,00) 1D
12 նոյ, 08:01:47 GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DMN...
Open
0,06 €
High
0,06 €
Low
0,06 €
Mkt. cap
140,09 մլն
Avg. vol.
0,00
Volume
0,00
52-wk high
1,80 €
52-wk low
0,05 €
No. of employees
42
Open
0,06 €
High
0,06 €
Low
0,06 €
Mkt. cap
140,09 մլն
Avg. vol.
0,00
Volume
0,00
52-wk high
1,80 €
52-wk low
0,05 €
No. of employees
42
News stories
From web sources and news partners
Trefis
·
17 րոպե առաջ
S&P 500 Movers | Winners: SNDK, BE, MU | Losers: ABNB, LULU, MCD
TradingView
·
1 ժամ առաջ
Stock Market: Will S&P 500 Open Up or Down Today?
FOREX.com
·
13 ժամ առաջ
S&P 500 Forecast: SPX rebounds amid revived AI enthusiasm
Traders Union
·
9 ժամ առաջ
Peter Tuchman: S&P 500 gains over $900 billion in market cap, closing up 1.3 percent
Profile
Diamyd Medical AB is a small biotechnology company headquartered in Stockholm, Sweden that focuses on immune modifying therapies for type-1 diabetes. The company's investigational drug retogatein is based on a recombinant form of GAD₆₅, one of two human glutamate decarboxylase gene products.
The company is headquartered in Stockholm, and maintains a "biomanufacturing" facility in Umeå which utilizes bacuolavirus-mediated protein expression. Wikipedia
About Diamyd Medical AB